Trial Profile
The effect of Cinnopar on bone density, serum phosphorus and calcium levels in postmenopausal women with osteoporosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Dec 2017
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 20 Dec 2017 New trial record